Glucagon-like peptide-1 receptor agonist (GLP-1RA) medications are frequently prescribed for the treatment of type 2 diabetes mellitus (T2DM) and for weight loss in overweight or obese patients with or without T2DM1. Here, GLP1R is linked to type 2 diabetes mellitus.